Predicting breast cancer behavior by microarray analysis

por van de Vijver, M
Publicado 2003

Loss of heterozygosity for defined regions on chromosomes 3, 11 and 17 in carcinomas of the uterine cervix.

por Kersemaekers, A. M., Hermans, J., Fleuren, G. J., van de Vijver, M. J.
Publicado 1998

Genetic alterations in ductal carcinoma in situ and invasive carcinoma of the breast

por Robanus-Maandag, E, Bosch, C, Vos, C, Peterse, H, van de Vijver, M
Publicado 2000

Immunohistochemical categorisation of ductal carcinoma in situ of the breast

por Meijnen, P, Peterse, J L, Antonini, N, Rutgers, E J Th, van de Vijver, M J
Publicado 2008

A specific gene expression signature for visceral organ metastasis in breast cancer

por Savci-Heijink, C. D., Halfwerk, H., Koster, J., Horlings, H. M., van de Vijver, M. J.
Publicado 2019

Loss of Bcl-2 in invasive breast cancer is associated with high rates of cell death, but also with increased proliferative activity.

por van Slooten, H. J., van de Vijver, M. J., van de Velde, C. J., van Dierendonck, J. H.
Publicado 1998

Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome

por Faneyte, I F, Schrama, J G, Peterse, J L, Remijnse, P L, Rodenhuis, S, van de Vijver, M J
Publicado 2003

HLA-G Expression Is an Independent Predictor for Improved Survival in High Grade Ovarian Carcinomas

por Rutten, M. J., Dijk, F., Savci-Heijink, C. D., Buist, M. R., Kenter, G. G., van de Vijver, M. J., Jordanova, E. S.
Publicado 2014

Epithelial-to-mesenchymal transition status of primary breast carcinomas and its correlation with metastatic behavior

por Savci-Heijink, C. D., Halfwerk, H., Hooijer, G. K. J., Koster, J., Horlings, H. M., Meijer, S. L., van de Vijver, M. J.
Publicado 2019

Histological type and marker expression of the primary tumour compared with its local recurrence after breast-conserving therapy for ductal carcinoma in situ

por Bijker, N, Peterse, J L, Duchateau, L, Robanus-Maandag, E C, Bosch, C A J, Duval, C, Pilotti, S, van de Vijver, M J
Publicado 2001

Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow-up

por Olivier, R I, van Beurden, M, Lubsen, M A C, Rookus, M A, Mooij, T M, van de Vijver, M J, van't Veer, L J
Publicado 2004

Long-term impact of the 70-gene signature on breast cancer outcome

por Drukker, C. A., van Tinteren, H., Schmidt, M. K., Rutgers, E. J. Th., Bernards, R., van de Vijver, M. J., van’t Veer, L. J.
Publicado 2014

Prognosis and prognostic factors of patients with mesothelioma: a population-based study

por van der Bij, S, Koffijberg, H, Burgers, J A, Baas, P, van de Vijver, M J, de Mol, B A J M, Moons, K G M
Publicado 2012

DNA ploidy of primary breast cancer and local recurrence after breast-conserving therapy.

por Beerman, H., Bonsing, B. A., van de Vijver, M. J., Hermans, J., Kluin, P. M., Caspers, R. J., van de Velde, C. J., Cornelisse, C. J.
Publicado 1991

Spatial interplay of lymphocytes and fibroblasts in estrogen receptor-positive HER2-negative breast cancer

por Nederlof, I., Hajizadeh, S., Sobhani, F., Raza, S. E. A., AbdulJabbar, K., Harkes, R., van de Vijver, M. J., Salgado, R., Desmedt, C., Kok, M., Yuan, Y., Horlings, H. M.
Publicado 2022

E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis.

por Vos, C. B., Cleton-Jansen, A. M., Berx, G., de Leeuw, W. J., ter Haar, N. T., van Roy, F., Cornelisse, C. J., Peterse, J. L., van de Vijver, M. J.
Publicado 1997

Expression of Bcl-2 in node-negative breast cancer is associated with various prognostic factors, but does not predict response to one course of perioperative chemotherapy.

por van Slooten, H. J., Clahsen, P. C., van Dierendonck, J. H., Duval, C., Pallud, C., Mandard, A. M., Delobelle-Deroide, A., van de Velde, C. J., van de Vijver, M. J.
Publicado 1996

Robust prognostic value of a knowledge-based proliferation signature across large patient microarray studies spanning different cancer types

por Starmans, M H W, Krishnapuram, B, Steck, H, Horlings, H, Nuyten, D S A, van de Vijver, M J, Seigneuric, R, Buffa, F M, Harris, A L, Wouters, B G, Lambin, P
Publicado 2008

Overexpression of P70 S6 kinase protein is associated with increased risk of locoregional recurrence in node-negative premenopausal early breast cancer patients

por van der Hage, J A, van den Broek, L J C M, Legrand, C, Clahsen, P C, Bosch, C J A, Robanus-Maandag, E C, van de Velde, C J H, van de Vijver, M J
Publicado 2004

Molecular subtypes of breast cancer and amplification of topoisomerase IIα: predictive role in dose intensive adjuvant chemotherapy

por Hannemann, J, Kristel, P, van Tinteren, H, Bontenbal, M, van Hoesel, Q G C M, Smit, W M, Nooij, M A, Voest, E E, van der Wall, E, Hupperets, P, de Vries, E G E, Rodenhuis, S, van de Vijver, M J
Publicado 2006